- Home
- AYI vs EXAS Comparison
AYI vs EXAS Comparison
Compare AYI & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AYI
- EXAS
- Stock Information
- Founded
- AYI 2001
- EXAS 1995
- Country
- AYI United States
- EXAS United States
- Employees
- AYI N/A
- EXAS N/A
- Industry
- AYI Building Products
- EXAS Medical Specialities
- Sector
- AYI Consumer Discretionary
- EXAS Health Care
- Exchange
- AYI Nasdaq
- EXAS Nasdaq
- Market Cap
- AYI 8.4B
- EXAS 8.6B
- IPO Year
- AYI N/A
- EXAS N/A
- Fundamental
- Price
- AYI $326.83
- EXAS $47.47
- Analyst Decision
- AYI Hold
- EXAS Strong Buy
- Analyst Count
- AYI 5
- EXAS 22
- Target Price
- AYI $340.60
- EXAS $66.43
- AVG Volume (30 Days)
- AYI 270.6K
- EXAS 4.0M
- Earning Date
- AYI 09-30-2025
- EXAS 08-06-2025
- Dividend Yield
- AYI 0.22%
- EXAS N/A
- EPS Growth
- AYI 3.17
- EXAS N/A
- EPS
- AYI 12.69
- EXAS N/A
- Revenue
- AYI $4,168,800,000.00
- EXAS $2,939,949,000.00
- Revenue This Year
- AYI $14.58
- EXAS $14.61
- Revenue Next Year
- AYI $8.88
- EXAS $12.71
- P/E Ratio
- AYI $25.75
- EXAS N/A
- Revenue Growth
- AYI 9.16
- EXAS 12.55
- 52 Week Low
- AYI $216.81
- EXAS $38.81
- 52 Week High
- AYI $345.30
- EXAS $72.83
- Technical
- Relative Strength Index (RSI)
- AYI 62.62
- EXAS 52.00
- Support Level
- AYI $311.24
- EXAS $44.90
- Resistance Level
- AYI $323.14
- EXAS $46.26
- Average True Range (ATR)
- AYI 7.42
- EXAS 1.88
- MACD
- AYI -0.12
- EXAS 0.61
- Stochastic Oscillator
- AYI 90.45
- EXAS 94.03
About AYI Acuity Brands Inc.
Acuity is a leading industrial technology company that offers lighting, lighting controls, and intelligent building solutions. Acuity, Inc. designs, manufactures, and brings to market products and services relating to these and other offerings. Acuity, Inc. has two reportable segments: Acuity Brands Lighting and Acuity Intelligent Spaces. ABL sells commercial, architectural, and specialty lighting, including components and control systems. AIS offers building management and audio/visual solutions to help make buildings intelligent.
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.